Rachel Abrams
๐ค SpeakerVoice Profile Active
This person's voice can be automatically recognized across podcast episodes using AI voice matching.
Appearances Over Time
Podcast Appearances
From The New York Times, I'm Rachel Abrams, and this is The Daily.
In the last few years, GLP-1 drugs like Ozempic and Zepbound have been radically reshaping the lives of millions of Americans.
They have the power to change everything, from our appetites and our health to the clothes that we buy.
But they also have the power to affect other parts of our lives, how we date, how we see ourselves, even our closest relationships.
Today, my colleague Lisa Miller tells the story of how these drugs upended one couple's marriage and how they dealt with the fallout.
It's Tuesday, October 7th.
Lisa, I don't think it's an understatement to say that we, in 2025, are in the middle of this, what feels like kind of a weight loss revolution in the United States.
And, of course, we're talking about these drugs that everybody's probably heard of, Ozempic, Wegovi, Monjaro.
I think most people know somebody who's been transformed by them.
Maybe a lot of people themselves have actually had some experience with them.
But I would just like to hear a little bit about what interested you initially.
How did you go about trying to find the right people to talk to to satisfy that question?
So it sounds like basically even though they might have liked each other or he certainly liked her, they did not get together in high school.
Now, we know that they eventually get together, right?
They seem like fun people.
They enjoy living life with gusto.
It's like in this moment she's almost caught between her old self and her new self.